artg posts
FeedPosted Nov 2nd 2010 4:20PM by Jon Ogg (RSS feed)
Filed under: Oracle Corp (ORCL), BP p.l.c. ADS (BP), S and P 500, DJIA, NASDAQ

Today was a day that was media-heavy on election day as the markets were pricing in some Republican party recovery in the House and Senate. That remains to be known until tonight, barring any recounts or run-offs. The other issue that added support was the hope of a large quantitative easing measure tomorrow at 2:15 PM EST. Much of that is supposed to be priced in and the verdict is still out. Either way, this was a solid day where stocks rose, bond prices rose, oil rose, and gold all rose.
Here are today's unofficial closing bell levels:
Dow Jones 11,188.72 +64.10 (0.58%)
S&P 500 1,193.57 +9.19 (0.78%)
Nasdaq 2,533.52 +28.68 (1.14%)
Top Analyst CallsContinue reading Closing Bell: An Electoral Market Win Ahead of QE2 (BP, ORCL, ARTG, CGNX, MPEL, WFR, NTRI)
Posted Feb 16th 2010 11:00AM by Eric Buscemi (RSS feed)
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Intel (INTC), Chevron Corp (CVX), ConocoPhillips (COP), Analyst Initiations
Analyst Upgrades
- Auriga upgraded Intel (INTC) to buy from hold to reflect the stock's relative valuation after channel checks indicated PC shipment plans continue to be solid. The firm raised its target price on shares to $24 from $20.
- Deutsche Bank upgraded RenaissanceRE (RNR) to buy from hold on valuation and believes stock buybacks and reserve releases will drive the company's growth. The firm raised its target price on shares to $65 from $59.
- UBS upgraded Philip Morris (PM) to buy from neutral based on increased confidence in its earnings outlook and relative valuation. The firm raised its target to $54 from $49.
- Chevron (CVX) was raised to outperform from market perform at Bernstein.
- Barnes & Noble (BKS) was upgraded to sell from conviction sell at Goldman Sachs.
- Deutsche Bank (DB) was upgraded to outperform from neutral at Credit Suisse.
Continue reading Analyst Upgrades, Downgrades and Initiations: ADI, CI, COP, CVX, DB, INTC, JCP, PM ...
Posted Feb 25th 2009 10:45AM by Eric Buscemi (RSS feed)
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, AT and T (T), Chubb Corp (CB), Analyst Initiations, General Dynamics Corp (GD)
Analyst upgrades:
- Banc of America/Merrill upgraded DPL Inc (NYSE: DPL) to Neutral from Underperform following the settlement agreement with staff of the Public Utilities Commission of Ohio on Electric Security Plan.
- Friedman Billings upgraded SeaBright Insurance (NYSE: SBX) to Outperform from Market Perform on valuation as they believe shares are oversold at current levels. Despite upgrading, the firm lowered its target price to $14 from $16.
- JP Morgan upgraded AT&T (T) to Overweight from Neutral as it believes upside earnings revisions are likely in 2009 due to the company's conservative wireline margin outlook. The firm finds the stock's valuation attractive at current levels and raised their target on shares to $28 from $24.
- Chubb (NYSE: CB) was upgraded to buy from Neutral at UBS.
- Cascal B.V. (NYSE: HOO) was raised to Outperform from Neutral at Credit Suisse.
- Healthcare Realty Trust (NYSE: HR) was upgraded at Keefe Bruyette to Outperform from Market Perform.
Continue reading Analyst upgrades, downgrades and initiations: T, FSLR, CEPH, CB ...
Posted Jun 18th 2008 12:38PM by Eric Buscemi (RSS feed)
Filed under: Analyst Reports, Analyst Initiations
MOST NOTEWORTHY: Pioneer Southwest, Art Technology and Real Goods Solar were today's noteworthy initiations:
- Friedman Billings initiated Pioneer Southwest (NYSE: PSE) with an Outperform rating and $25 target. The firm believes the current valuation does not reflect potential upside from the upstream drop-downs, which would result in higher distributions.
- ThinkPanmure believes Art Technology (NASDAQ: ARTG) is well-positioned to benefit from a strong replatforming cycle. Shares were initiated with a Buy rating and $4.50 target.
- Broadpoint said Real Goods Solar (NASDAQ: RSOL) has a disciplined operational model leading to profitable growth, and started shares with a Buy rating and $10 target. ThinkPanmure also initiated Real Goods Solar with a Buy rating and $10 target and said the company is well-positioned given strong underlying trends that include higher retail electricity costs, legislative renewable energy standards and incentives, declining solar photovoltaic systems costs, and "green momentum."
OTHER INITIATIONS:
Posted Nov 29th 2007 12:33PM by Beth Gaston Moon (RSS feed)
Filed under: Technical Analysis, Personal Finance, Bargain Stocks, Stocks to Buy
Art Technology Group (NASDAQ:
ARTG) dabbles in the fine art of business, providing software that helps with customer-service needs, including online-sales management. Included on the firm's roster of past and present clients are
Best Buy (NYSE:
BBY),
Citibank (NYSE:
C), and
Target (NYSE:
TGT).
When the company last visited the earnings confessional in late October, it reported a 64% jump in revenue to $35.9 million, thanks in large part to gains in services revenue. For fiscal 2007, ARTG expects to bank revenue of $130 million to $133 million, with a small net loss of $5 million to $7 million expected for the full year as well.
For much of the past decade, ARTG has struggled in penny-stock territory. From early 2002 through early 2006, the stock enjoyed precious little movement north of the $2.00 zone. Currently, thanks to some recent solid price action, ARTG shares are trading in territory not explored in nearly six years. In the wake of last month's earnings report, the stock spiked higher to overtake its April 2006 peak and pass the $4.00 level.
Continue reading 10 Stocks Under $10: Art Technology Group (ARTG)
Posted Jul 19th 2007 11:15AM by Kevin Shult (RSS feed)
Filed under: Before the Bell, Analyst Reports, Analyst Upgrades and Downgrades, Alcoa Inc (AA)
MOST NOTEWORTHY: Alcoa (AA), Rigel Pharma (RIGL), Isis Pharma (ISIS), Cytokinetics (CYTK) and F5 Networks (FFIV) were today's noteworthy initiations:
- RBC believes shares are expensive, but feels Alcoa (NYSE: AA) has put itself in play and a bid for the company is possible. The firm resumed coverage with a Sector Perform rating and a $51 target.
- Credit Suisse initiated Rigel Pharmaceuticals (NASDAQ: RIGL) with an Outperform rating, believing R788 in ITP alone justifies current value, while RA and pipeline provide potential upside.
- Isis Pharmaceuticals (NASDAQ: ISIS) was initiated with a Buy rating and $17 target at Jefferies; the firm believes Isis's pipeline holds promise and appears under appreciated at the current valuation.
- Credit Suisse is positive on Cytokinetics (NASDAQ: CYTK) congestive heart failure candidate CK-453 and views the market as undeserved, starting shares with an Outperform rating and $15 target.
- Unterberg initiated shares of F5 Networks (NASDAQ: FFIV) with a Market Perform based on valuation...
OTHER INITIATIONS:
- Banc of America started Grant Prideco (NYSE: GRP) share with a Buy rating and $67 target.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).